Orna Mor

ORCID: 0000-0003-3207-4226
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • SARS-CoV-2 and COVID-19 Research
  • HIV Research and Treatment
  • HIV/AIDS drug development and treatment
  • Hepatitis B Virus Studies
  • HIV/AIDS Research and Interventions
  • Hepatitis C virus research
  • Viral gastroenteritis research and epidemiology
  • SARS-CoV-2 detection and testing
  • Hepatitis Viruses Studies and Epidemiology
  • Liver Disease Diagnosis and Treatment
  • COVID-19 Clinical Research Studies
  • Animal Virus Infections Studies
  • HIV, Drug Use, Sexual Risk
  • Biosensors and Analytical Detection
  • Viral Infections and Immunology Research
  • Vaccine Coverage and Hesitancy
  • Parvovirus B19 Infection Studies
  • Liver Disease and Transplantation
  • CRISPR and Genetic Engineering
  • Molecular Biology Techniques and Applications
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Virus-based gene therapy research
  • Cytomegalovirus and herpesvirus research
  • vaccines and immunoinformatics approaches
  • Animal Disease Management and Epidemiology

Sheba Medical Center
2016-2025

Israel Ministry of Health
2016-2025

Tel Aviv University
2016-2025

University of Oxford
2021

Ministry of Environmental Protection
2017

University of Cologne
2016

Ben-Gurion University of the Negev
2016

Ministry of Health of the Russian Federation
2013

Quark Pharmaceuticals (United States)
2001-2005

Weizmann Institute of Science
2004

Hypoxia is an important factor that elicits numerous physiological and pathological responses. One of the major gene expression programs triggered by hypoxia mediated through hypoxia-responsive transcription hypoxia-inducible 1 (HIF-1). Here, we report identification cloning a novel HIF-1-responsive gene, designated RTP801. Its strong up-regulation was detected both in vitro vivo animal model ischemic stroke. When induced from tetracycline-repressible promoter, RTP801 protected MCF7 PC12...

10.1128/mcb.22.7.2283-2293.2002 article EN cc-by Molecular and Cellular Biology 2002-04-01

<h2>Summary</h2><h3>Background</h3> Antiretroviral therapy (ART) is crucial for controlling HIV-1 infection through wide-scale treatment as prevention and pre-exposure prophylaxis (PrEP). Potent tenofovir disoproxil fumarate-containing regimens are increasingly used to treat prevent HIV, although few data exist frequency risk factors of acquired drug resistance in regions hardest hit by the HIV pandemic. We aimed do a global assessment after virological failure with first-line...

10.1016/s1473-3099(15)00536-8 article EN cc-by The Lancet Infectious Diseases 2016-01-29

<ns3:p>Late in 2020, two genetically-distinct clusters of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with mutations biological concern were reported, one the United Kingdom and South Africa. Using a combination data from routine surveillance, genomic sequencing international travel we track dispersal lineages B.1.1.7 B.1.351 (variant 501Y-V2). We account for potential biases surveillance efforts by including passenger volumes location where lineage was first London Africa...

10.12688/wellcomeopenres.16661.2 preprint EN cc-by Wellcome Open Research 2021-09-17

<ns3:p>Late in 2020, two genetically-distinct clusters of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with mutations biological concern were reported, one the United Kingdom and South Africa. Using a combination data from routine surveillance, genomic sequencing international travel we track dispersal lineages B.1.1.7 B.1.351 (variant 501Y-V2). We account for potential biases surveillance efforts by including passenger volumes location where lineage was first London Africa...

10.12688/wellcomeopenres.16661.1 preprint EN cc-by Wellcome Open Research 2021-05-19

The immunogenicity and safety of the Pfizer-BioNTech BNT162b2 mRNA vaccine in people living with human immunodeficiency virus type 1 (PLWH) are unknown. We aimed to assess this PLWH.In prospective open study, we enrolled 143 PLWH, aged ≥18 years, who attended our clinic 261 immunocompetent health-care workers (HCWs). Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) receptor binding domain (RBD) IgG neutralizing antibodies were measured. Adverse events, viral load CD4 cell counts...

10.1016/j.cmi.2021.07.031 article EN publisher-specific-oa Clinical Microbiology and Infection 2021-08-24

SARS-CoV-2 Delta (B.1.617.2) variant of concern (VOC) and other VOCs are spreading in Europe. Micro-neutralisation assays with sera obtained after Comirnaty (BNT162b2, BioNTech/Pfizer) vaccination 36 healthcare workers (31 female) demonstrated significant fold change reduction neutralising titres compared the original virus: Gamma (P.1) 2.3, Beta (B.1.351) 10.4, 2.1 2.6. The Alpha (B.1.1.7) was not significant. Despite being lower, remaining neutralisation capacity conferred by against is...

10.2807/1560-7917.es.2021.26.26.2100557 article EN cc-by Eurosurveillance 2021-07-01

Investigation of SARS-CoV-2 spread and identification variants in sewers has been demonstrated to accurately detect prevalence viral strains is advantageous clinical sampling population catchment size. Herein, we utilized an established nationwide system wastewater concentration approaches perform large-scale surveillance nine different locations across Israel that were sampled from August 2020 February 2021 sequenced (n = 58). Viral sequences obtained the samples had high coverages genome,...

10.1016/j.scitotenv.2021.148002 article EN cc-by The Science of The Total Environment 2021-05-24

Background. Numerous studies have shown that baseline drug resistance patterns may influence the outcome of antiretroviral therapy. Therefore, guidelines recommend testing to guide choice initial regimen. In addition optimizing individual patient management, these data enable transmitted (TDR) be surveyed for public health purposes. The SPREAD program systematically collects gain insight into TDR occurring in Europe since 2001.

10.1093/cid/civ963 article EN cc-by-nc-nd Clinical Infectious Diseases 2015-11-29

"Ampicillin rash," a phenomenon unique to patients with Epstein-Barr virus acute infectious mononucleosis (AIM) treated ampicillin, was first reported in the 1960s. The incidence estimated as being between 80% and 100%, figures have not been reviewed since those accounts. We sought establish current of rash associated antibiotic treatment among children AIM.A retrospective study all hospitalized diagnosed having AIM based upon positive serology 2 pediatric tertiary medical centers Israel.Of...

10.1542/peds.2012-1575 article EN PEDIATRICS 2013-04-16

Genomic sequencing provides critical information to track the evolution and spread of SARS-CoV-2, optimize molecular tests, treatments vaccines, guide public health responses. To investigate spatiotemporal heterogeneity in global SARS-CoV-2 genomic surveillance, we estimated impact intensity turnaround times (TAT) on variant detection 167 countries. Most countries submit genomes >21 days after sample collection, 77% low middle income sequenced <0.5% their cases. We found that at least 0.5%...

10.1101/2021.08.21.21262393 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2021-08-26

Abstract One of the key questions regarding COVID19 vaccines is whether they can reduce viral shedding. To date, Israel vaccinated substantial parts adult population, which enables extracting real world signals. The vaccination rollout started on Dec 20th 2020, utilized mainly BNT162b2 vaccine, and focused individuals who are 60 years or older. By now, more than 75% this age group have been at least 14 days after first dose, compared to 25% between ages 40-60 old. Here, we traced Ct value...

10.1101/2021.02.08.21251329 preprint EN cc-by-nd medRxiv (Cold Spring Harbor Laboratory) 2021-02-08

A nosocomial outbreak of SARS-CoV-2 Delta variant infected 42 patients, staff and family members; 39 were fully vaccinated. The attack rate was 10.6% (16/151) among exposed reached 23.7% (23/97) patients in a highly vaccinated population, 16-26 weeks after vaccination (median: 25 weeks). All cases linked traced to one patient. Several transmissions occurred between individuals wearing face masks. Fourteen 23 became severely sick or died, raising question about possible waning immunity.

10.2807/1560-7917.es.2021.26.39.2100822 article EN cc-by Eurosurveillance 2021-09-30

This study presents an analysis of the epidemiological trends parvovirus B19 (B19V) in Israel from 2010 to 2023, with particular emphasis on outbreak 2023. The utilized molecular diagnostic data individual patients obtained at Central Virology Laboratory. Between and 2022, 8.5% PCR-tested samples were positive for B19V, whereas this percentage surged 31% samples. Throughout period, annual cycles consistently peaked early spring/summer, most recent prominent occurring 2016. Predominantly,...

10.3390/v16030480 article EN cc-by Viruses 2024-03-20

Integrase strand transfer inhibitors (INSTIs) are expected to be widely adopted globally, requiring surveillance of resistance emergence and transmission.We therefore sought develop a standardized list INSTI-resistance mutations suitable for the transmitted INSTI resistance.To characterize suitability HIV-1 drug (TDR) surveillance, we classified them according their presence on published expert lists, conservation in INSTI-naive persons, frequency INSTI-treated persons contribution reduced...

10.1093/jac/dkz417 article EN Journal of Antimicrobial Chemotherapy 2019-09-12
Vladimir Kartashev Matthias Döring Leonardo Nieto Eleda Coletta Rolf Kaiser and 95 more Saleta Sierra A. Guerrero Heribert Stoiber Christian Paar Anne–Mieke Vandamme Frederik Nevens Marc Van Ranst Lize Cuypers P. Braun Robert Ehret Martin Obermeier Sebastian Schneeweiß Stefan Scholten Konstanze D. Römer K Isernhagen Nishat Tasnim Qurashi Eva Heger Elena Knops Maria Neumann‐Fraune Jörg Timm Andreas Walker Nadine Lübke Heiner Wedemeyer Julian Schulze zur Wiesch Marc Lütgehetmann Susanne Polywka Martin Däumer Dieter Hoffmann Ulrike Protzer Nadia Marascio Alfredo Focà Maria Carla Liberto Giorgio Settimo Barreca Luisa Galati Carlo Torti Vincenzo Pisani Carlo Federico Perno Francesca Ceccherini‐Silberstein Valeria Cento M. Ciotti Maurizio Zazzi Barbara Rossetti Andrea De Luca C. Caudai Orna Mor Carole Seguin‐Devaux Thérèse Staub Fernando Araújo Perpétua Gómes Joaquim Cabanas Nikolay Markin Ю. Г. Хоменко M. V. Govorukhina G.I. Lugovskaya Д. В. Донцов Antonio Más Elisa Martró Verónica Saludes Francisco Rodríguez‐Frías Féderico García Paz Casas Alberto de la Iglesia Juan Carlos Alados María José Pena-López Mario Rodríguez-Domínguez Juan Carlos Galán Adolfo Suárez Laura Cardeñoso Michelle Guerrero C. Vegas-Dominguez J. Blas-Espada Rafael Rubio Silvia García‐Bujalance Laura Benítez‐Gutiérrez Carmen de Mendoza Natalia Montiel José Ramón Santos Isabel Viciana Ana Sofia Delgado P.A. Martínez-Sanchez Miriam Fernández‐Alonso Gabriel Reina Matilde Trigo Miguel Echeverria Antonio Aguilera Daniel Navarro Samuel Bernal María Constanza Lozano Felipe Fernández-Cuenca Antonio Orduña José Marı́a Eiros Bouza Raúl Ortíz de Lejarazu Ana Martínez-Sapiña Andrés García‐Díaz Tanzina Haque

HCV affects 185 million people worldwide and leads to death morbidities. has a high genetic diversity is classified into seven genotypes 67 subtypes. Novel anti-HCV drugs (Direct-Acting-Antivirals) eligibility, resistance cure rates depend on geno/subtype (GT).Analysis of epidemiological information viral GT from patients undergoing genotyping in 2011-2015.Anonymized 52 centers was analyzed retrospectively.37,839 samples were included the study. We show that distribution similar throughout...

10.1016/j.jcv.2016.05.010 article EN cc-by-nc-nd Journal of Clinical Virology 2016-05-24

The COVID-19 pandemic and the fast global spread of disease resulted in unprecedented decline world trade travel. A critical priority is, therefore, to quickly develop serological diagnostic capacity identify individuals with past exposure SARS-CoV-2. In this study serum samples obtained from 309 persons infected by SARS-CoV-2 324 healthy, uninfected as well 7 patients 4-7 each ranging between 1-92 days post first positive PCR were tested an "in house" ELISA which detects IgM, IgA IgG...

10.1371/journal.pone.0241164 article EN cc-by PLoS ONE 2020-11-23
A Howe Chaturaka Rodrigo Evan B. Cunningham Mark W. Douglas Julia Dietz and 95 more Jason Grebely Stephanie Popping Javier Alejandro Sfalcin Miłosz Parczewski Christoph Sarrazin Adolfo de Salazar Ana Fuentes Murat Sayan Josep Quer Midori Kjellin Hege Kileng Orna Mor Johan Lennerstrand Slim Fourati V.C. Di Maio Vladimir Chulanov Jean‐Michel Pawlotsky P. Richard Harrigan Francesca Ceccherini‐Silberstein Féderico García Marianne Martinello Gail Matthews Fay Fabián Fernando Juan Ignacio Esteban Beat Müllhaupt Julian Schulze zur Wiesch Peter Buggisch Christoph Neumann‐Haefelin Thomas Berg Christoph P. Berg Jörn M. Schattenberg Christophe Moreno Rudolf Stauber Andrew R. Lloyd Gregory J. Dore Tanya Applegate Juan Ignacio Damir García‐Cehic Josep Gregori Francisco Rodríguez‐Frías Ariadna Rando‐Segura Yael Gozlan M. Angélico Massimo Andreoni Sergio Babudieri Ada Bertoli Valeria Cento Nicola Coppola Antonio Craxı̀ Stefania Paolucci Giustino Parruti C. Pasquazzi Carlo Federico Perno Elisabetta Teti C. Vironet Anders Lannergård Ann‐Sofi Duberg Soo Aleman Tore Jarl Gutteberg Alexandre Soulier Aurélie Gourgeon Stéphane Chevaliez Stanislas Pol Fabrice Carrat Dominique Salmon‐Céron Rolf Kaiser Elena Knopes Perpétua Gómes Rob de Kneght Bart Rijnders Mario Poljak Maja M. Lunar Rafael Usubillaga Carole Seguin‐Devaux Enoch Tay Caroline Wilson Dao Sen Wang Jacob George Jen Kok Ana Belén Pérez Natalia Chueca Miguel García Deltoro Ana Martínez-Sapiña María Magdalena Lara-Pérez Silvia García‐Bujalance Teresa Aldámiz‐Echevarría Francisco Jesús Vera-Méndez Juan A. Pineda Marta Casado J.M. Pascasio Javier Salmerón Juan Carlos Alados Antonio Poyato Francisco Téllez António Rivero‐Juarez

•An international cohort of 3,355 patients with hepatitis C from 22 countries was evaluated for drug resistance following DAA therapy.•Nearly all harbored drug-resistant variants after treatment failure, over 2/3 having against ≥2 classes.•Pathways to included enrichment highly resistant and selection multiple variants.•Previously unrecognized in who failed NS5A inhibitors were identified at high frequencies.•Resistance frequent older people cirrhosis those infected genotypes 1b 4 failure....

10.1016/j.jhepr.2022.100462 article EN cc-by-nc-nd JHEP Reports 2022-02-24

Objective To quantify and characterise missed opportunities for earlier HIV diagnosis in patients diagnosed with advanced HIV. Design A retrospective observational cohort study. Setting central tertiary medical centre Israel. Measures The proportion of HIV, the to diagnose them earlier, rate clinical indicator diseases (CIDs) those patients. Results Between 2010 2015, 356 were 118 (33.4%) late, 57 (16%) disease. Old age (OR=1.45 (95% CI 1.16 1.74)) being heterosexual (OR=2.65 1.21 5.78))...

10.1136/bmjopen-2016-012721 article EN cc-by-nc BMJ Open 2016-11-01

Abstract Introduction : Transmitted drug‐resistance mutations (TDRM) may hamper successful anti‐HIV‐1 therapy and impact future control of the HIV‐1 epidemic. Recently infected, therapy‐naïve individuals are best suited for surveillance such TDRM. In this study, TDRM, detected by next‐generation sequencing (NGS) were compared to those identified Sanger‐based population (SBS) in recently infected patients. Methods Historical samples from 80 patients, diagnosed between 2000 2014, analysed...

10.7448/ias.20.1.21846 article EN cc-by Journal of the International AIDS Society 2017-01-01

HIV-1 RNA monitoring, both before and during antiretroviral therapy, is an integral part of HIV management worldwide. Measurements viral loads are expected to assess the copy numbers all common subtypes accurately be equally sensitive at different loads. In this study, we compared for first time performance NucliSens v2.0, RealTime HIV-1, Aptima Quant Dx, Xpert load assays. Plasma samples (n = 404) were selected on basis their v2.0 results subtypes. Concordance, linear regression,...

10.1128/jcm.01806-15 article EN Journal of Clinical Microbiology 2015-09-02

HBsAg immune-escape mutations can favor HBV-transmission also in vaccinated individuals, promote immunosuppression-driven HBV-reactivation, and increase fitness of drug-resistant strains. Stop-codons enhance HBV oncogenic-properties. Furthermore, as a consequence the overlapping structure genome, some or stop-codons derive from drug-resistance RT. This study is aimed at gaining insight prevalence characteristics immune-associated escape mutations, chronically HBV-infected patients...

10.1186/s12879-018-3161-2 article EN cc-by BMC Infectious Diseases 2018-06-01

The BNT162b2 messenger RNA (mRNA) vaccine against severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has been shown to be safe and effective in immunocompetent patients. safety efficacy of this liver transplantation (LT) recipients is still under evaluation. objective study was assess the among transplant recipients. immune responses 76 LT receiving doses were compared with those 174 age‐matched controls. Postvaccination immunoglobulin G (IgG) antibodies receptor‐binding domain...

10.1002/lt.26366 article EN Liver Transplantation 2021-11-12

Mutations in the p53 gene are most common genetic alterations found human malignancies. In this study, a search was done for mutations conserved regions of malignant mesotheliomas. Thirteen mesotheliomas collected over preceding 12 yr and maintained paraffin blocks were examined by polymerase chain reaction (PCR) followed both single-strand conformation polymorphism (SSCP) denaturing gradient-gel electrophoresis (DGGE). Direct sequence analysis performed cases suspected mutations. No exons 5...

10.1165/ajrcmb.16.1.8998073 article EN American Journal of Respiratory Cell and Molecular Biology 1997-01-01
Coming Soon ...